Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Mass Spectrometry-Based Proteomic Profiling of Patient-Derived Prostate Tumor Explants

Molecular and Cellular Proteomics - United States
doi 10.1074/mcp.ra118.000633